Product
Metformin-Sitagliptin-Empaglifozin-Pioglitazone
1 clinical trial
1 indication
Indication
Type 2 DiabetesClinical trial
A Prospective, Randomized, Parallel-group, Adaptive Design Phase IIb/III, Multicenter Study, to Assess the Efficacy of Polychemotherapy for Inducing Remission of Newly Diagnosed Type 2 Diabetes.Status: Active (not recruiting), Estimated PCD: 2024-03-02